Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana M. Chudzinski-Tavassi"'
Autor:
Aline R. M. Lobba, Miryam Paola Alvarez-Flores, Melissa Regina Fessel, Marcus Vinicius Buri, Douglas S. Oliveira, Renata N. Gomes, Priscila S. Cunegundes, Carlos DeOcesano-Pereira, Victor D. Cinel, Ana M. Chudzinski-Tavassi
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Salivary glands are vital structures responsible for successful tick feeding. The saliva of ticks contains numerous active molecules that participate in several physiological processes. A Kunitz-type factor Xa (FXa) inhibitor, similar to the tissue f
Externí odkaz:
https://doaj.org/article/555884386be24d9ea33c4470bba4c752
Autor:
Durvanei A. Maria, Sonia Elisabete A.L. Will, Rosemary V. Bosch, Jean G. Souza, Juliana M. Sciani, Mauricio B. Goldfeder, Giuliana G. Rondon, Ana M. Chudzinski-Tavassi
Publikováno v:
Toxicology Reports, Vol 6, Iss , Pp 51-63 (2019)
Amblyomin-X, a Kunitz-type protease inhibitor, is a recombinant protein that selectively induces apoptosis in tumor cells and promotes tumor reduction in vivo in melanoma animal models. Furthermore, Amblyomin-X was able to drastically reduce lung met
Externí odkaz:
https://doaj.org/article/10194f3bcbaf480f88ffcab08a20c7d6
Autor:
Mario T F Pacheco, Carolina M Berra, Kátia L P Morais, Juliana M Sciani, Vania G Branco, Rosemary V Bosch, Ana M Chudzinski-Tavassi
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e111907 (2014)
Amblyomin-X is a Kunitz-type recombinant protein identified from the transcriptome of the salivary glands of the tick Amblyomma cajennense and has anti-coagulant and antitumoral activity. The supposed primary target of this molecule is the proteasome
Externí odkaz:
https://doaj.org/article/575ef158a76a4f7e805b70e8407e3605